Circulating tumour DNA: a challenging innovation to develop "precision onco-surgery" in pancreatic adenocarcinoma.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the third leading cause of cancer-related mortality within the next decade. Management of PDAC remains challenging with limited effective treatment options and a dismal long-term prognosis. Liquid biopsy and circulating biomarkers seem to be promising to improve the multidisciplinary approach in PDAC treatment. Circulating tumour DNA (ctDNA) is the most studied blood liquid biopsy analyte and can provide insight into the molecular profile and individual characteristics of the tumour in real-time and in advance of standard imaging modalities. This could pave the way for identifying new therapeutic targets and markers of tumour response to supplement diagnostic and provide enhanced stratified treatment. Although its specificity seems excellent, the current sensitivity of ctDNA remains a limitation for clinical use, especially in patients with a low tumour burden. Increasing evidence suggests that ctDNA is a pertinent candidate biomarker to assess minimal residual disease after surgery but also a strong independent prognostic biomarker. This review explores the current knowledge and recent developments in ctDNA as a screening, diagnostic, prognostic and predictive biomarker in the management of resectable PDAC but also technical and analytical challenges that must be overcome to move toward "precision onco-surgery."

• Authors: Daniel Pietrasz, Elisabetta Sereni, Francesco Lancelotti, Antonio Pea, Claudio Luchini, Giulio Innamorati, Roberto Salvia, Claudio Bassi
• Journal: British journal of cancer (Br J Cancer) Vol. 126 Issue 12 Pg. 1676-1683 (06 2022) ISSN: 1532-1827 [Electronic] England
• PMID: 35197581 (Publication Type: Journal Article, Review)
• Copyright: © 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Chemical References

• Biomarkers, Tumor
• Circulating Tumor DNA

Topics

• Adenocarcinoma (diagnosis, genetics, surgery)
• Biomarkers, Tumor (genetics)
• Carcinoma, Pancreatic Ductal (diagnosis, genetics, surgery)
• Circulating Tumor DNA (genetics)
• Humans
• Pancreatic Neoplasms (diagnosis, genetics, surgery)
• Prognosis
• Pancreatic Neoplasms